Sort
30,917 grants matching “tumor microenvironment”
TR&D Project 3
$290,858Jamie Berta Spangler · Johns Hopkins University · P41 · FY2025 · EB
Multi-Scale Optical Imaging of the Cancer Vasculature and Tumor Microenvironment
$290,832Seok H Yun · Methodist Hospital Research Institute · U54 · FY2011 · CA
Molecular Pathology and Genomics Core
$290,824Jon C Aster · Dana-Farber Cancer Inst · P01 · FY2019 · CA
Inflammation and Immunosuppression in Lung Cancer
$290,768Cong Yan · Indiana University Indianapolis · R01 · FY2013 · CA
The biology of blood-testis barrier dynamics
$290,755C. Yan Cheng · Population Council · R01 · FY2011 · HD
The biology of blood-testis barrier dynamics
$290,755C. Yan Cheng · Population Council · R01 · FY2012 · HD
Regulatory Mechanisms Controlling Breast Tissue Development and Transformation
$290,754Anthony N Imbalzano · Univ Of Massachusetts Med Sch Worcester · P01 · FY2012 · CA
Regulatory Mechanisms Controlling Breast Tissue Development and Transformation
$290,752Anthony N Imbalzano · Univ Of Massachusetts Med Sch Worcester · P01 · FY2011 · CA
Project 3: Inter-Relationships and Prognostic Significance of Breast Cancer Radiomic Risk Features, Tissue Microenvironment, and Adiposity
$290,738John Alan Shepherd · University Of Hawaii At Manoa · P20 · FY2023 · CA
Effects of MUC1 expression on erbB activity in neoplasia
$290,735Joyce A Schroeder · University Of Arizona · R01 · FY2006 · CA
Project 2 Intrathecal Anti-PD-1 Immunotherapy for Metastatic Melanoma Patients with Leptomeningeal Disease (LMD)
$290,680Jennifer A. Wargo · University Of Tx Md Anderson Can Ctr · P50 · FY2021 · CA
Enhancing Radiation Therapy: Vascular Targeting Agents
$290,666Dietmar W Siemann · University Of Florida · R01 · FY2006 · CA
Mechanisms & Therapeutic Targeting of the Microenvironment in Pancreatic Cancer
$290,661Douglas Hanahan · Dana-Farber Cancer Inst · P01 · FY2007 · CA
Project 4: Combined use of immunotherapy and targeted treatments for triple negative breast cancer
$290,647Kornelia Polyak · Dana-Farber Cancer Inst · P50 · FY2022 · CA
Project 3 Gene Mediated Cytotoxic Immmunotherapy for GBM
$290,642E. Antonio Chiocca · Massachusetts General Hospital · P01 · FY2018 · CA
Project 3 Gene Mediated Cytotoxic Immmunotherapy for GBM
$290,642E. Antonio Chiocca · Massachusetts General Hospital · P01 · FY2020 · CA
Project 3 Gene Mediated Cytotoxic Immmunotherapy for GBM
$290,642E. Antonio Chiocca · Massachusetts General Hospital · P01 · FY2021 · CA
Stromal modulation of response to Thymidylate synthase inhibitors
$290,641Maria Marjorette Pena · University Of South Carolina At Columbia · R01 · FY2015 · CA
Stromal modulation of response to Thymidylate synthase inhibitors
$290,641Maria Marjorette Pena · University Of South Carolina At Columbia · R01 · FY2011 · CA
Stromal modulation of response to Thymidylate synthase inhibitors
$290,641Maria Marjorette Pena · University Of South Carolina At Columbia · R01 · FY2012 · CA
Dystroglycan in Epithelial Architecture and Function
$290,637John L Muschler · California Pacific Med Ctr Res Institute · R01 · FY2009 · CA
Dystroglycan in Epithelial Architecture and Function
$290,637John L Muschler · California Pacific Med Ctr Res Institute · R01 · FY2008 · CA
Engineered tumor-specific T cells Resist Hypoxic-Tumor Immunosuppressive Attacks.
$290,421Patricia Yotnda · Baylor College Of Medicine · R01 · FY2013 · CA
The alpha2beta1 Integrin and Tumor Metastasis
$290,420Mary M. Zutter · Vanderbilt University · R01 · FY2013 · CA
Prevention of MGUS Progression to MM by Modulating the Bone Marrow Microenvironment
$290,400Fenghuang Zhan · Baylor College Of Medicine · U54 · FY2023 · CA